Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization

MLA

Phuc LeHoang, et al. “Three-Year Visual and Anatomic Results of Administrating Intravitreal Bevacizumab in Inflammatory Ocular Neovascularization.” Canadian Journal of Ophthalmology, vol. 47, June 2012, pp. 269–74. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4729269c3761a15cf555ef592dbbddd9&authtype=sso&custid=ns315887.

APA

Phuc LeHoang, Blanche Ghandour, Ahmad M. Mansour, Yukari Jo, Arnd Heiligenhaus, J. Fernando Arevalo, Shree Kurup, Thomas Ness, Christine Fardeau, Georg Spital, Rainer Guthoff, Yasushi Ikuno, Cem Küçükerdönmez, Friederike Mackensen, Nicholas F. Hrisomalos, Emily N. Hrisomalos, Focke Ziemssen, Jad Akesbi, Alfredo Adán, … Timothy Y Y Lai. (2012). Three-year visual and anatomic results of administrating intravitreal bevacizumab in inflammatory ocular neovascularization. Canadian Journal of Ophthalmology, 47, 269–274.

Chicago

Phuc LeHoang, Blanche Ghandour, Ahmad M. Mansour, Yukari Jo, Arnd Heiligenhaus, J. Fernando Arevalo, Shree Kurup, et al. 2012. “Three-Year Visual and Anatomic Results of Administrating Intravitreal Bevacizumab in Inflammatory Ocular Neovascularization.” Canadian Journal of Ophthalmology 47 (June): 269–74. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4729269c3761a15cf555ef592dbbddd9&authtype=sso&custid=ns315887.